117 related articles for article (PubMed ID: 22646815)
1. On the origin of matrix metalloproteinase-2 and -9 in blood platelets.
Wrzyszcz A; Wozniak M
Platelets; 2012; 23(6):467-74. PubMed ID: 22646815
[TBL] [Abstract][Full Text] [Related]
2. Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients.
Fernández Bello I; Álvarez MT; López-Longo FJ; Arias-Salgado EG; Martín M; Jiménez-Yuste V; Rodríguez de la Rúa A; Butta NV
Thromb Haemost; 2012 Jan; 107(1):88-98. PubMed ID: 22116092
[TBL] [Abstract][Full Text] [Related]
3. Release of matrix metalloproteinases-1 and -2, but not -9, from activated platelets measured by enzyme-linked immunosorbent assay.
Kälvegren H; Jönsson S; Jonasson L
Platelets; 2011; 22(8):572-8. PubMed ID: 21756063
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
[TBL] [Abstract][Full Text] [Related]
5. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB
Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2.
Fernandez-Patron C; Martinez-Cuesta MA; Salas E; Sawicki G; Wozniak M; Radomski MW; Davidge ST
Thromb Haemost; 1999 Dec; 82(6):1730-5. PubMed ID: 10613662
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
[TBL] [Abstract][Full Text] [Related]
9. Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin.
Falcinelli E; Giannini S; Boschetti E; Gresele P
Br J Haematol; 2007 Jul; 138(2):221-30. PubMed ID: 17593030
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.
Menchén L; Marín-Jiménez I; Arias-Salgado EG; Fontela T; Hernández-Sampelayo P; Rodríguez MC; Butta NV
Gut; 2009 Jul; 58(7):920-8. PubMed ID: 19039088
[TBL] [Abstract][Full Text] [Related]
11. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
[TBL] [Abstract][Full Text] [Related]
12. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
Ottino P; He J; Axelrad TW; Bazan HE
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273
[TBL] [Abstract][Full Text] [Related]
13. Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration.
Kim TH; Mars WM; Stolz DB; Michalopoulos GK
Hepatology; 2000 Jan; 31(1):75-82. PubMed ID: 10613731
[TBL] [Abstract][Full Text] [Related]
14. Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets.
Radomski A; Jurasz P; Sanders EJ; Overall CM; Bigg HF; Edwards DR; Radomski MW
Br J Pharmacol; 2002 Dec; 137(8):1330-8. PubMed ID: 12466243
[TBL] [Abstract][Full Text] [Related]
15. Localization and translocation of MMP-2 during aggregation of human platelets.
Sawicki G; Sanders EJ; Salas E; Wozniak M; Rodrigo J; Radomski MW
Thromb Haemost; 1998 Nov; 80(5):836-9. PubMed ID: 9843180
[TBL] [Abstract][Full Text] [Related]
16. Developmentally regulated expression of matrix metalloproteinases during fetal rat colon morphogenesis.
Kurakata H; Oka M; Matsubara Y; Niwa T; Utsunomiya H; Fujishiro M; Miki K; Fukamachi H; Kubota S; Ichinose M
Dev Growth Differ; 2008 Jan; 50(1):41-8. PubMed ID: 17986262
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil P-selectin-glycoprotein-ligand-1 binding to platelet P-selectin enhances metalloproteinase 2 secretion and platelet-neutrophil aggregation.
Abou-Saleh H; Théorêt JF; Yacoub D; Merhi Y
Thromb Haemost; 2005 Dec; 94(6):1230-5. PubMed ID: 16411399
[TBL] [Abstract][Full Text] [Related]
19. Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia.
Planas AM; Solé S; Justicia C
Neurobiol Dis; 2001 Oct; 8(5):834-46. PubMed ID: 11592852
[TBL] [Abstract][Full Text] [Related]
20. Experimental hindlimb ischemia leads to neutrophil-mediated increases in gastrocnemius MMP-2 and -9 activity: a potential mechanism for ischemia induced MMP activation.
Muhs BE; Gagne P; Plitas G; Shaw JP; Shamamian P
J Surg Res; 2004 Apr; 117(2):249-54. PubMed ID: 15047130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
